{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:59:06Z","timestamp":1783814346309,"version":"3.55.0"},"reference-count":28,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"unspecified","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V038281\/1"],"award-info":[{"award-number":["MR\/V038281\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,2,7]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Up to 50% of kidney transplant patients are diagnosed with delayed graft function (DGF) following transplantation\u2014the majority being linked to ischaemia reperfusion injury (IRI). DGF is traditionally defined as the requirement for dialysis during the first week after transplantation and is associated with inferior graft and patient outcomes. Local synthesis of complement components, largely by the renal tubule, plays a critical role in IRI. We have developed Mirococept, a membrane-targeted complement inhibitor, that can be administered to the donor kidney ex vivo prior to transplantation. After administration, Mirococept is retained in the donor organ, thereby minimising the risk of systemic side effects. We previously launched the EMPIRIKAL study aiming to evaluate the efficacy of Mirococept in reducing DGF in deceased-donor kidney transplantation (KT). The funding body recommended termination of the study to allow a dose-saturating study before the next stage of clinical evaluation. This was carried out in a porcine kidney model and led to a revised dosing regimen for EMPIRIKAL-2 (60\u2013180\u2009mg compared with 5\u201325\u2009mg in the initial trial). The EMPIRIKAL-2 trial (REC 24\/NE\/0071) aims to identify the most safe and efficacious dose of Mirococept to reduce DGF rate in deceased-donor KT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>EMPIRIKAL-2 is a Phase IIa multicentre double-blind randomised controlled trial (RCT) with an initial safety run. Participants will be recruited from renal departments at National Health Service tertiary hospital sites in the UK. The purpose of the safety run is to assess the tolerance of each of the three proposed Mirococept doses (60, 120 or 180\u2009mg), before the RCT begins. Three patients will be assigned to each treatment dose, starting from the lower dose. The safety run will be considered successful if at least one dose can be taken forward to the RCT for comparison to placebo.<\/jats:p>\n                    <jats:p>If safety is met, 144 participants (36 per arm excluding drop-outs) will be randomised to all doses meeting the safety criteria or placebo on a 1:1:1:1 basis. The primary endpoint is DGF, defined as the requirement for dialysis during the first week after transplantation. Safety evaluation will include the monitoring of laboratory data and the recording of all adverse events. Immunosuppression therapy, antibiotic and antiviral prophylaxis will be administered as per local centre protocols. Enrolment in the RCT is anticipated to take approximately 12 months, and patients will be followed-up for 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study has been approved by the Northeast - Newcastle and North Tyneside 2 Research Ethics Service Committee, REC reference 24\/NE\/0071. The results of the study will be reported and disseminated at international conferences and in peer-reviewed scientific journals. Once published, a lay summary of the results will be made available to participants who request this information.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"isrctn\" xlink:href=\"ISRCTN14279222\">ISRCTN14279222<\/jats:ext-link>\n                      . Registered on 4 July 2024.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Protocol version<\/jats:title>\n                    <jats:p>2.0 dated 9 May 2024.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-097029","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T07:17:25Z","timestamp":1741331845000},"page":"e097029","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Multicentre, multi-arm, double-blind randomised placebo-controlled dose-finding trial investigating the safety and Efficacy of MirococePt (APT070) In Reducing delayed graft function In the Kidney ALlograft (EMPIRIKAL-2): study protocol for a randomised controlled trial"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"isrctn14279222","registry":"10.18810\/isrctn"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6291-1278","authenticated-orcid":false,"given":"Theodoros","family":"Kassimatis","sequence":"first","affiliation":[{"name":"Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King\u2019s College London, London, UK"},{"name":"King\u2019s Kidney Care, King\u2019s College Hospital, London, UK"},{"name":"Transplant, Renal and Urology Directorate, Guy's and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alima","family":"Rahman","sequence":"additional","affiliation":[{"name":"Clinical Trial Management Service, Research and Development, Guy's and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayyad","family":"Jaradat","sequence":"additional","affiliation":[{"name":"Transplant, Renal and Urology Directorate, Guy's and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel","family":"Douiri","sequence":"additional","affiliation":[{"name":"School of Life Course and Population Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Delord","sequence":"additional","affiliation":[{"name":"School of Life Course and Population Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseanna","family":"Greenlaw","sequence":"additional","affiliation":[{"name":"Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Palmer Joyce","sequence":"additional","affiliation":[{"name":"Clinical Trial Management Service, Research and Development, Guy's and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathon","family":"Olsburgh","sequence":"additional","affiliation":[{"name":"Transplant, Renal and Urology Directorate, Guy's and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Khurram","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Transplantation, The Royal London Hospital, London, UK"},{"name":"William Harvey Research Institute, Queen Mary University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Ghazanfar","sequence":"additional","affiliation":[{"name":"Renal and Transplant Unit, St George\u2019s Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4837-9446","authenticated-orcid":false,"given":"Simon","family":"Knight","sequence":"additional","affiliation":[{"name":"Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Friend","sequence":"additional","affiliation":[{"name":"Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna","family":"Shah","sequence":"additional","affiliation":[{"name":"King\u2019s Kidney Care, King\u2019s College Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Killbride","sequence":"additional","affiliation":[{"name":"Kent Kidney Care Centre, East Kent Hospitals University NHS Foundation Trust, Canterbury, Kent, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Smith","sequence":"additional","affiliation":[{"name":"School of Immunology and Microbial Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Sacks","sequence":"additional","affiliation":[{"name":"Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"2025120519354570000_15.3.e097029.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03754.x"},{"key":"2025120519354570000_15.3.e097029.2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.06.005"},{"key":"2025120519354570000_15.3.e097029.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01852.x"},{"key":"2025120519354570000_15.3.e097029.4","unstructured":"Shoskes DA , Cecka JM . Effect of delayed graft function on short- and long-term kidney graft survival. Clin Transpl 1997;297\u2013303."},{"key":"2025120519354570000_15.3.e097029.5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn667"},{"key":"2025120519354570000_15.3.e097029.6","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182855544"},{"key":"2025120519354570000_15.3.e097029.7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02380","article-title":"The Role of Complement in Organ Transplantation","volume":"10","author":"Grafals","year":"2019","journal-title":"Front Immunol"},{"key":"2025120519354570000_15.3.e097029.8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.7.3883"},{"key":"2025120519354570000_15.3.e097029.9","doi-asserted-by":"publisher","DOI":"10.1038\/nm0602-582"},{"key":"2025120519354570000_15.3.e097029.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63503-1"},{"key":"2025120519354570000_15.3.e097029.11","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.3.1517"},{"key":"2025120519354570000_15.3.e097029.12","doi-asserted-by":"publisher","DOI":"10.1038\/nri3225"},{"key":"2025120519354570000_15.3.e097029.13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0804186"},{"key":"2025120519354570000_15.3.e097029.14","doi-asserted-by":"publisher","DOI":"10.1006\/prep.1995.0003"},{"key":"2025120519354570000_15.3.e097029.15","doi-asserted-by":"publisher","DOI":"10.1042\/bst0301037"},{"key":"2025120519354570000_15.3.e097029.16","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200011)43:11<2590::AID-ANR29>3.0.CO;2-R"},{"key":"2025120519354570000_15.3.e097029.17","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20546"},{"key":"2025120519354570000_15.3.e097029.18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706286"},{"key":"2025120519354570000_15.3.e097029.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2007.07.016"},{"key":"2025120519354570000_15.3.e097029.20","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005101116"},{"key":"2025120519354570000_15.3.e097029.21","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1016\/j.molimm.2007.06.021","article-title":"Membrane-localising complement inhibitors\u2014clinical progress","volume":"44","author":"Smith","year":"2007","journal-title":"Mol Immunol"},{"key":"2025120519354570000_15.3.e097029.22","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-017-1972-x","article-title":"A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial","volume":"18","author":"Kassimatis","year":"2017","journal-title":"Trials"},{"key":"2025120519354570000_15.3.e097029.23","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/ajt.16265","article-title":"Ex vivo delivery of Mirococept: A dose-finding study in pig kidney after showing a low dose is insufficient to reduce delayed graft function in human kidney","volume":"21","author":"Kassimatis","year":"2021","journal-title":"Am J Transplant"},{"key":"2025120519354570000_15.3.e097029.24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/nep.12277","article-title":"Influence of allograft weight to recipient bodyweight ratio on outcome of cadaveric renal transplantation","volume":"19","author":"Codas","year":"2014","journal-title":"Nephrology (Carlton)"},{"key":"2025120519354570000_15.3.e097029.25","first-page":"635","article-title":"Duration of delayed graft function and outcomes after kidney transplantation from controlled donation after circulatory death donors: a retrospective study","volume":"32","author":"Shamali","year":"2019","journal-title":"Transpl Int"},{"key":"2025120519354570000_15.3.e097029.26","first-page":"1375","article-title":"Randomized phase II clinical trials","volume":"69","author":"Simon","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"2025120519354570000_15.3.e097029.27","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182a19348"},{"key":"2025120519354570000_15.3.e097029.28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012237","article-title":"Protocol of a randomised controlled, open-label trial of ex vivo normothermic perfusion versus static cold storage in donation after circulatory death renal transplantation","volume":"7","author":"Hosgood","year":"2017","journal-title":"BMJ Open"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-097029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T03:35:54Z","timestamp":1764992154000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-097029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,6]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bmjopen-2024-097029"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-097029","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}